MyDx, Inc. (OTCQB:MYDX) is a science and technology company that created the first multi-use handheld chemical analyzer device for cannabis professionals and retail marijuana consumers to measure the chemical content of their cannabis.
Now Read: MyDx Introduces Bluetooth Smart-Vape
The company just announced this morning that they've filed a lawsuit against their former Chief Operating Officer in order to protect their new AeroDx Diagnostic Platform.
Here's the Details of the Lawsuit
On July 14, 2017, MyDx and its CEO, Daniel Yazbeck, filed a complaint in Superior Court of California.
The lawsuit is against a series of defendants including the company's former COO, who have allegedly engaged in unfair business practices, made false statements about MyDx, its products, and Mr. Yazbeck at investor events and on online investor platforms.
There can be no assurance about the results or on the outcome of this lawsuit, however, the company took aggressive steps that it felt were necessary to protect its business and its shareholders.
Now Read: Makers of G-Pen Granted $47 Million in Counterfeit Case
We'll keep readers posted as more information unfolds regarding MyDx's recently announced lawsuit. For the full press release announcing the lawsuit, click here.
Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer via social media on Facebook, Twitter, StockTwits, and Instagram.